from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2088/pknJ

LFCtreatmentdescriptionclass of inhibitor

0.514

Amikacinug/mL Amikacintranslation

0.151

Cap5-10ug/mL Capreomycintranslation

1.108

Rox10-50 ug/mL Roxithromycintranslation

1.004

SM2-5 ug/mL Streptomycintranslation

-2.302

Tet5-10 ug/mL Tetracyclinetranslation

0.690

Rif0.2-5ug/mL Rifampicintranscription

1.004

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.743

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.615

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.045

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.758

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.331

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.375

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.682

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.411

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.275

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.749

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.402

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.197

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.460

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.588

Nigericin50 uM Nigericinrespiration

-0.268

TRC10-150 ug/mL Triclosanrespiration

-0.991

TRZ10-25 ug/mL Thioridazinerespiration

0.207

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.645

menadione6-10 ug/mL Menadionerespiration

0.112

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.220

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.267

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.792

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.242

NRP_1Non-replicating persistence stage 1dosRassociated

-0.234

Amp0.2mg/mL AmpicillincellWall

-0.164

Cephalexin20-100 ug/mL CephalexincellWall

0.467

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.634

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.676

EMB10-20 ug/mL EthambutolcellWall

-0.172

Eta12-40 ug/mL EthionamidecellWall

0.172

INH0.2-0.4 ug/mL IsoniazidcellWall

0.144

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.066

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.960

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.282

BZA0.12 mg/mL BenzamidearomaticAmides

0.101

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.014

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.968

H2O24 mM hydrogen peroxideDNAdamaging

0.235

Levo10 ug/mL LevofloxacinDNAdamaging

0.535

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.338

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.268

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.585

UVUV-irradiationDNAdamaging

-1.159

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.445

Antimycin12.5-50 ug/mL Antimycin A?

-1.272

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.321

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.206

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.501

PA8240.2-2 ug/mL PA-824?

0.551

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.657

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.073

Verapamil50 uM Verapamil?

-0.973

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.364

methoxatin10-20 ug/mL Methoxatin?